Compare WCN & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WCN | RMD |
|---|---|---|
| Founded | 1997 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9B | 34.0B |
| IPO Year | 2005 | 1996 |
| Metric | WCN | RMD |
|---|---|---|
| Price | $159.99 | $229.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 10 |
| Target Price | $204.21 | ★ $292.56 |
| AVG Volume (30 Days) | 810.6K | ★ 1.2M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | 0.85% | ★ 1.13% |
| EPS Growth | ★ 74.48 | 9.67 |
| EPS | 2.02 | ★ 10.43 |
| Revenue | ★ $9,466,915,000.00 | $2,957,013,000.00 |
| Revenue This Year | $6.14 | $10.60 |
| Revenue Next Year | $6.18 | $7.41 |
| P/E Ratio | $79.08 | ★ $20.93 |
| Revenue Growth | 6.14 | ★ 13.44 |
| 52 Week Low | $146.89 | $180.27 |
| 52 Week High | $179.74 | $284.87 |
| Indicator | WCN | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 48.96 |
| Support Level | $154.57 | $218.39 |
| Resistance Level | $172.77 | $233.75 |
| Average True Range (ATR) | 2.45 | 5.92 |
| MACD | -0.57 | -2.43 |
| Stochastic Oscillator | 31.04 | 28.01 |
Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.